Dr. Jadranka Dragovic, MD

Dr. Dragovic practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Dragovic's NPI, 1093875403, was assigned on December 8, 2006. Dr. Dragovic graduated from University of Belgrade Faculty of Medicine in 1977. Dr. Dragovic holds Michigan license 048151.

Dr. Dragovic's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Dr. Dragovic's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Dragovic is also affiliated with Henry Ford Macomb Hospital. The medical group on file is Henry Ford Health. Dmand AI also links Dr. Dragovic to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dragovic practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Dragovic's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Dragovic is board certified in therapeutic radiology by the American Board of Radiology. Dmand AI has Dr. Dragovic's licenses on file in 2 states: Michigan and New York.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Dragovic treats.

CMS data shows 225 Medicare services from Dr. Dragovic across 4 procedure codes in 2024, for 88 Medicare patients. Medicare paid $17,745 for them.

CMS counts 88 Medicare patients who saw Dr. Dragovic in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have cancer, and 70% have high cholesterol. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dragovic's median patient age at 73, with 47% women.

In 2024, Dr. Dragovic wrote 16 Medicare Part D claims. 94% of them were for generic drugs. They cover 2 drugs, with $745 in total drug cost. In 2021, CMS named 15 claims across 1 drug.

Dr. Dragovic accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Dragovic, published from 2012 to 2022. 2019 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Adenocarcinoma and Antineoplastic Agents. Dr. Dragovic has published most often in Int J Radiat Oncol Biol Phys. Dr. Dragovic's most frequent co-authors are Rachit Kumar, MD, Christopher James Anker, MD and Percy Po-Yih Lee, MD.

CMS Open Payments shows 3 general payments to Dr. Dragovic from 2 drug and device companies in 2017. Travel and lodging make up the largest share, 98% of the total. Viewray Technologies Inc paid the most, $713.

Dmand AI lists 4 awards for Dr. Dragovic, most recently CMS Stage 1 EHR in 2013.

Dr. Dragovic graduated from University of Belgrade Faculty of Medicine in 1977. Dr. Dragovic is a member of ASCO.

Dr. Dragovic is in network with 12 carriers, including Health Alliance Plan, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.